Analysis of in vitro immunization: Generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells

Cancer Immunology, Immunotherapy

Volumn 52, Issue 3, 2003, Pages 171-178

  Glazyrin, Alexey L ^a   Kan Mitchell, June ^a   Mitchell, Malcolm S ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Anti tumor vaccine; Melanoma; RNA; Tumor lysate

Indexed keywords

HLA A ANTIGEN; MONOPHENOL MONOOXYGENASE; RNA;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNIZATION; MELANOMA CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; RNA EXTRACTION;

EID: 0037382968     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0339-6     Document Type: Article

References (25)

1. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86
2. Berard F, Blanco P, Davoust J, Neidhart-Berard E-M, Nouri-Shirazi M, Taquet N, Rimoldi D, Cerottini J-C, Banchereau J, Palucka AK (2000) Cross-priming of naïve CD8 cells against melanoma antigen using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192:1535
3. Boczkowski D, Nair SK, Nam J-H, Layerly HK, Gilboa R (2000) Induction of tumor immunity and cytotoxic T lymphocytes responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 60:1028
4. Browning M, Petronozelli F, Bicknell D, Krausa P, Rowan A, Tonks S, Murray N, Bodmer J, Bodmer W (1996) Mechanism of loss of HLA class I molecules expression on colorectal tumor cells. Tissue Antigens 47:364
5. Browning MJ, Madrigal JA, Krausa P, Kowalski H, Allsoop CE, Little AM, Turne S, Adams EJ, Arnett KL, Bodmer WF (1995) The HLA-A, B, C genotype of the class 1 negative cell line Daudi reveal novel HLA-A and B alleles. Tissue Antigen 45:177
6. Eisenbach L, Bar-Haim E, El-Ahami K (2000) Antitumor vaccination using peptide-based vaccines. Immunol Lett 74:27
7. Fields RC, Shimzu K, Mule JJ (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 95:9482
8. Glazyrin AE, Adsay VN, Vaitkevicius VK, Sarkar FH (2001) CD95-related apoptotic machinery is functional in pancreatic cancer cells. Pancreas 22:357
9. Goulder PJR, Tang Y, Brander C, Michael R, Betts MC, Altfeld M, Annamalai K, Trocha A, He S, Rosenberg ES, Ogge G, O'Callaghan CA, Kalams SA, McKinney RE, Mayer JK, Koup RA, Pelton SI, Burchett SK, McIntosh K, Walker BD (2000) Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children J Exp Med 192:1819
10. Gruber A, Kan-Mitchell J, Kuhen KE, Mukai T, Wong-Staal F (2000) Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 96:1327
11. Heiser A, Maurice MA, Yancey DR, Wu NZ, Dahm P, Pruitt SK, Bockowski D, Nair SK, Ballo MS, Gilboa E, Vieweg J (2001) Induction of policlonal prostate cancer specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol 166:2953
12. Lambert LA, Gibson GR, Maloney M, Barth RJ Jr (2001) Equipotent generation of protective antitumor immunity by methods of dendritic cell loading with whole cell tumor. J Immunother 24:323
13. Minev BR, Chavez FL, Mitchell MS (1999) Cancer vaccines: novel approaches and new promise. Pharmacol Ther 81:121
14. Mitchell MS (1998) Perspective on allogeneic melanoma lysates in active specific immunotherapy. Semin Oncol 6:623
15. Mitchell MS, Darrah D, Yeung D, Halpern S, Wallace A, Voland J, Jones V, Kan-Mitchell J (2002) Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol 20:1075
16. Nouri-Surazi M, Banchereau J, Fay J, Palucka K (2000) Dendritic cell based tumor vaccines. Immunol Lett 74:5
17. Pardoll DM(1998) Cancer vaccines. Nat Med 4:25
18. Qiu L, Zhang M, Sturm RA, Gardiner B, Tonks I, Kay G, Parsons PG. (2000) Inhibition of melanin synthesis by cystamine in human melanoma cells. J Invest Dermatol 114:21
19. Rubio-Godoy V, Dutoit V, Rimorlldi D, Lienard D, Lejeune F, Speiser D, Guillaume P, Cerottni J-J, Romero P, Valmori D (2001) Discrepancy between ELISPOT IFN-γ sectretion and binding of A2/peptide miltimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life. Proc Natl Acad Sci USA 98:10302
20. Schultze JL, Anderson KC, Gilleece MH, Gribben JG, Nadler LM (2001) A pilot study of combined immunotherapy with autologous adoptive tumor-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2. Br J Haematol 113:455
21. Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, Murray A (2000) Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res 60:6441
22. Tighe H, Corr M., Roman E, Raz I (1998) Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today 19:89
23. Valmori D, Pittel MJ, Vonarbourg C, Rimoldi D, Lienard D, Speiser D, Dunbar R, Cerundolo V, Cerolini J-H, Romero P (1999) Analysis of the cytolitic T lymphocytes of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Cancer Res 59:4050
24. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, de Plean E, van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643
25. Yang MX, Cederbaum AI (1997) Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1. Arch Biochem Biophys 341:25